CLYM
Climb Bio, Inc. Common Stock
CLYM
CLYM
71 hedge funds and large institutions have $278M invested in Climb Bio, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 7 closing their positions.
Holders
71
Holders Change
+24
Holders Change %
+51.06%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
31
Increased
28
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$9.5M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$7.76M |
3 |
ABG
3
Ally Bridge Group
New York
|
$6.26M |
4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$3.43M |
5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$3.01M |